Researchers at the Gladstone Institute of Neurological Disease have identified processes that may explain how a key protein, apolipoprotein E4 (apoE4), contributes to the development of Alzheimer's disease. Their findings, described in the Journal of Neuroscience (March 10, 2004), include identifying where in the brain apoE4 is broken down into toxic fragments that can impair the function and survival of nerve cells. Results of their study may point the way to a new therapeutic strategy for the prevention and treatment of Alzheimer's disease.
ApoE4 is the best known genetic risk factor for Alzheimer's disease, but, until now, the mechanism by which it increases that risk has remained a mystery. The key finding of the current study relates to apoE4's tendency to be broken down into toxic fragments when it is produced in neurons, the brain cells responsible for cognitive functions.
Proteins can be broken into small pieces by enzymes known as proteases in a process termed proteolysis. While the degradation of proteins is important for many cell processes, it can be harmful when it occurs inappropriately, not only because it destroys the protein, but also because abnormally high levels of fragments can damage cells.
In the new study, involving the examination of genetically engineered mice, Gladstone researchers have established that:
- only apoE4 produced by neurons is susceptible to fragmentation, unlike apoE4 produced by other brain cells;
- fragmentation is correlated with age, occurring more frequently the older the animal, similar to the effect of age on Alzheimer disease risk in humans;
- fragmentation of apoE4 occurs predominantly in the very parts of the brain that are most vulnerable to Alzheimer's disease, the neocortex and hippocampus. In contrast, fragmentation does not occur in the cerebellum, which is much less vulnerable to Alzheimer's disease;
- the apoE4 fragments cause
Contact: John Watson
University of California - San Francisco 23-Mar-2004Page: 1 2 Related biology news :1
. Gladstone investigator Mike McCune wins prestigious NIH Directors Pioneer Award2
. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director3
. Gladstone researchers find method to study hidden HIV reservoirs4
. New Gladstone/UCSF study finds inhibiting fat synthesis results in obesity resistance in mice5
. Gladstone/UCSF team discovers interaction of two brain proteins may be key factor in development of Alzheimers disease6
. AIDS Virus May Evolve Differently In Cerebrospinal Fluid Compared With Blood In Some Patients, UCSF/Gladstone Research Finds7
. UCSF/Gladstone Finding May Explain HIVS Ability To Infect Cells Lacking The Key Target Of HIV: The CD4 Receptor8
. Breakthrough In Understanding The Biology Of Fat-- UCSF/Gladstone Scientists Discover Gene For Key Enzyme9
. Student science contest participation influences study, career choices, alumni say10
. New study shows hope for treating inhalant abuse11
. International study findings link acne-like rash to effectiveness of new targeted cancer treatment